Results 91 to 100 of about 25,820 (298)
Veterinary and Comparative Oncology, EarlyView.ABSTRACT Chemotherapy can have adverse gastrointestinal effects in dogs and people. The objective of this study was to assess the impact of vincristine and prednisolone/prednisone, as part of a CHOP chemotherapy [cyclophosphamide, hydroxydaunorubicin, oncovin (vincristine) and prednisolone/prednisone] protocol, on gastrointestinal dysbiosis in dogs ...
Juan Aragon +10 more
wiley +1 more source
Nephrology, Dialysis and Transplantation, 2018 Background Elevated serum fibroblast growth factor 23 (FGF23) is strongly associated with cardiovascular risk and mortality. Tenapanor, an inhibitor of gastrointestinal sodium/hydrogen exchanger isoform 3, decreased serum phosphate in a randomized ...
G. Block +5 more
semanticscholar +1 more source
Hypophosphatemic effect of niacin extended release in ischemic kidney disease [PDF]
, 2015 Ischemic nephropathy is an emerging cause of end stage renal disease, associated with many co-morbidities especially cardiovascular disease risk and derangement in calcium-phosphorus homeostasis resulting in hyperphosphatemia, influencing bones, a ...
Dawani, Manohar Lal +2 more
core +1 more source
Linchuang shenzangbing zazhi, 2020 Objective To evaluate the efficacy and safety of ferric citrate in treatment of hyperphosphatemia in patients with chronic kidney disease（CKD）,and provide evidence-based basis for clinical medication.Methods The literature on randomized controlled trials（
WANG Shan-shan, WEN Tong, ZHANG Xin-zhou
doaj
Urinary Fractional Excretion of Phosphorus in Dogs with Spontaneous Chronic Kidney Disease
Veterinary Sciences, 2017 The increase of urinary fractional excretion of phosphorus (uFEP) may indicate phosphorus retention before the onset of hyperphosphatemia in the early stages of chronic kidney disease (CKD).
Cínthia Ribas Martorelli +6 more
doaj +1 more source
Clinical Endocrinology, Volume 102, Issue 6, Page 626-634, June 2025.ABSTRACT Pheochromocytoma and paraganglioma (together PPGL) are tumours with a high degree of heritability. Genetic landscape is divided into three clusters, cluster 1 (Krebs/pseudohypoxia signalling pathway), cluster 2 (kinase signalling pathway) and cluster 3 (Wnt signalling pathway).
Sakshi Jhawar +5 more
wiley +1 more source
The effect of intravenous vitamin C on the phosphorus level reduction in hemodialysis patients: A double blind randomized clinical trial [PDF]
, 2012 Aim The majority of hemodialysis patients are hyperphosphate-mic. Hyperphosphatemia in these patients can lead to renal oste-odystrophy, vascular calcifcation, cardiovascular events, and is independently associated with mortality risk.
Aarabi, M. +3 more
core
NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD
Kidney International Reports, 2018 Serum phosphate levels are insufficiently controlled in many patients with end-stage renal disease (ESRD), and novel therapeutic strategies are needed. Blocking intestinal phosphate absorption mediated by sodium-dependent phosphate co-transporter type 2b
Tobias E. Larsson +6 more
doaj +1 more source
Chinese Expert Consensus on Home Nutrition Administration for Older Patients (2024)
Journal of Evidence-Based Medicine, Volume 18, Issue 2, June 2025.ABSTRACT Families constitute important settings for the nutritional management of older adults, and there is a growing demand for continuous nutritional management services extending from hospital care to home‐based care. Since the publication of the Chinese Expert Consensus on Home Nutrition Administration for the Elderly (2017 Edition) 7 years ago ...
Jie Gong +6 more
wiley +1 more source
Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease
Drugs, 2018 Management of hyperphosphatemia in patients with dialysis-dependent chronic kidney disease remains a major challenge, requiring a multifaceted approach that includes dietary phosphate restriction, dialysis, and phosphate binders.
D. Fouque, M. Vervloet, M. Ketteler
semanticscholar +1 more source